JPRN-jRCT2080223008未知3 期
Efficacy and safety trial of AJG533 in patients with chronic constipation (Phase 3 study)
适应症
试验速览
- 阶段
- 3 期
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients with chronic constipation
排除标准
- •Patients with known or suspected organic constipation
- •Patients with known or suspected symptomatic constipation or drug-induced constipation
研究者
相似试验
未知
3 期
ong term study of AJG533 in patients with chronic constipatioChronic constipationJPRN-jRCT2080223007EA Pharma Co.,Ltd.360
未知
3 期
Phase III study of AJG511 in patients with active ulcerative colitisulcerative colitisJPRN-jRCT2080222653EA Pharma Co.,Ltd.120
未知
3 期
Phase III Clinical Study of AJG522 : Studies of safety and efficacy of AJG522 as a colon preparation agent for colonoscopy - Comparative study with MGV-5Patients scheduled for colonoscopyJPRN-jRCT2080221438Ajinomoto Pharmaceuticals Co., Ltd.
已完成
3 期
Phase III study of AJM300 in patients with active ulcerative colitis (2)Active Ulcerative ColitisJPRN-jRCT2080223867EA Pharma Co., Ltd.198
未知
2 期
Phase II study of AJG511 in patients with active ulcerative colitislcerative colitisJPRN-jRCT2080222245Ajinomoto Pharmaceuticals Co., Ltd.